What is Fernando Espinosa Abdalá's net worth in 2026?

As of 2026, Fernando Espinosa Abdalá's estimated net worth is $1.575 billion, ranking #2561 among the world's billionaires. The estimate is based on publicly available shareholding data and market prices, updated daily.

How did Fernando Espinosa Abdalá make their money?

Fernando Espinosa Abdalá's wealth primarily comes from Pharmaceuticals, most notably through Pharmaceuticals.

Where is Fernando Espinosa Abdalá from?

Fernando Espinosa Abdalá is from Mexico.

How old is Fernando Espinosa Abdalá?

Fernando Espinosa Abdalá is 76 years old.

Billionaire Profile

Global Rank

#2561

Fernando Espinosa Abdalá

CEO, Pharmaceuticals

Mexico City, Mexico

Real-Time Net Worth

$1.58B

Estimated based on Pharmaceuticals stock value as of September 10, 2026

0% (24h)

Age

Source

Pharmaceuticals

Industry

Healthcare

Citizenship

Mexico

Biography

Fernando Espinosa Abdalá, a 76-year-old Mexican billionaire, has a net worth of $1.6 billion as of March 24, 2026. His wealth originates from the pharmaceuticals industry, specifically through the sale of his drug manufacturer Rimsa to Teva Pharmaceutical Industries in 2016. Before the sale, Fernando served as the operational president of Rimsa, which his father founded in 1970. After the sale, Teva sued Fernando and his brother, though most charges were dismissed, with a subsequent settlement. He resides in Mexico City.

AI-Assisted Draft

Not yet reviewed by an editor — how we work

Data Updated

Sep 10, 2026

Report a Correction

Wealth Over Time

Net Worth History

Year	Net Worth	Global Rank	Source
2026	$1.58B	#2561	Forbes Real-Time
2025	$1.60B	—	Forbes List
2024	$1.60B	—	Historical Record

In-Depth Profile

Early Life

Fernando Espinosa Abdalá's journey began in Mexico, where his father founded a pharmaceutical distribution business in 1970. This marked the genesis of what would become a significant player in the Mexican pharmaceutical market.

Rise to Success

The family business evolved into manufacturing, eventually becoming known as Rimsa. Fernando served as the operational president, leading the company through its growth. The sale of Rimsa to Teva Pharmaceutical Industries for $2.3 billion in 2016 was a pivotal moment, solidifying the family's wealth.

Key Business Strategies

Rimsa's success was attributed to its range of patent-protected products, including innovative fixed-dose combination products. The company's ability to secure a deal with a major player like Teva reflects a strategic approach to business development and market positioning.

Philanthropy

While specifics on Fernando Espinosa Abdalá’s philanthropic endeavors are not readily available in the search results, it's worth noting that the family has maintained a low profile, focusing on privacy.

Career Milestones

1970

Rimsa Founding

Father founded the pharmaceutical distribution company, the precursor to Rimsa.

2016

Sale of Rimsa

Rimsa was sold to Teva Pharmaceutical Industries for $2.3 billion.

Controversies & Challenges